Display options
Cite
Altemir A, Iglesias-Sancho M, Barrabés-Torrella C, et al. Successful treatment of knee erythromelalgia with topical oxymetazoline. Clin Exp Dermatol. 2021;doi: 10.1111/ced.15060.
Altemir, A., Iglesias-Sancho, M., Barrabés-Torrella, C., Sanchez-Regaña, M., & Salleras-Redonnet, M. (2021). Successful treatment of knee erythromelalgia with topical oxymetazoline. Clinical and experimental dermatology, . https://doi.org/10.1111/ced.15060
Altemir, Arcadi, et al. "Successful treatment of knee erythromelalgia with topical oxymetazoline." Clinical and experimental dermatology vol. (2021). doi: https://doi.org/10.1111/ced.15060
Altemir A, Iglesias-Sancho M, Barrabés-Torrella C, Sanchez-Regaña M, Salleras-Redonnet M. Successful treatment of knee erythromelalgia with topical oxymetazoline. Clin Exp Dermatol. 2021 Dec 14; doi: 10.1111/ced.15060. Epub 2021 Dec 14. PMID: 34905256.
Copy Download .nbib Format: NLM
Share it on

Clin Exp Dermatol. 2021 Dec 14; doi: 10.1111/ced.15060. Epub 2021 Dec 14.

Successful treatment of knee erythromelalgia with topical oxymetazoline.

Clinical and experimental dermatology

Arcadi Altemir, Maribel Iglesias-Sancho, Cristina Barrabés-Torrella, Manuel Sanchez-Regaña, Montse Salleras-Redonnet

Affiliations

  1. Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Hospitalario Quironsalud, Barcelona, Spain.
  2. Clínica Dermacot, Mataró, Spain.

PMID: 34905256 DOI: 10.1111/ced.15060

Abstract

Erythromelalgia is an infrequent syndrome with a profound impact on quality of life. Its management is usually challenging and multiple treatments have been reported with variable response rates. To the best of our knowledge, we present the first case of erythromelalgia successfully treated with topical oxymetazoline.

© 2021 British Association of Dermatologists.

References

  1. Parker LK, Ponte C, Howell KJ et al. Clinical features and management of erythromelalgia: long term follow-up of 46 cases. Clin Exp Rheumatol 2017; 35: 80-4. - PubMed
  2. Mann N, King T, Murphy R. Review of primary and secondary erythromelalgia. Clin Exp Dermatol 2019; 44: 477-82. - PubMed
  3. Leroux MB. Erythromelalgia: a cutaneous manifestation of neuropathy? An Bras Dermatol 2018; 93: 86-94. - PubMed
  4. Patel NU, Shukla S, Zaki J, Feldman SR. Oxymetazoline hydrochloride cream for facial erythema associated with rosacea. Expert Rev Clin Pharmacol 2017; 10: 1049-54. - PubMed
  5. Davis MDP, Morr CS, Warndahl RA, Sandroni P. Topically applied midodrine, 0.2%, an α1-agonist, for the treatment of erythromelalgia. JAMA Dermatol 2015; 151: 1025-6. - PubMed

Publication Types